Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stephan Klessing"'
Autor:
Elie Richel, Jannik T. Wagner, Stephan Klessing, Riccardo Di Vincenzo, Vladimir Temchura, Klaus Überla
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundFc-fusion proteins have been successfully developed for therapeutic purposes, but are also a promising platform for the fast generation and purification of immunogens capable of inducing strong humoral immune responses in preclinical immuni
Externí odkaz:
https://doaj.org/article/fa5e0200210546b9819e91d6c35e2062
Autor:
Stephan Klessing, Antonia Sophia Peter, Kirsten Fraedrich, Jannik T. Wagner, Mirko Kummer, Janina Deutschmann, Philipp Steininger, Hans-Dieter Steibl, Klaus Überla
Publikováno v:
Viruses, Vol 15, Iss 2, p 397 (2023)
Live-attenuated SARS-CoV-2 vaccines present themselves as a promising approach for the induction of broad mucosal immunity. However, for initial safety assessment in clinical trials, virus production requires conditions meeting Good Manufacturing Pra
Externí odkaz:
https://doaj.org/article/cef303dff024458ca4eb53d2e12b97eb
Autor:
Stephan Klessing, Vladimir Temchura, Pierre Tannig, Antonia Sophia Peter, Dennis Christensen, Roland Lang, Klaus Überla
Publikováno v:
Vaccines, Vol 8, Iss 4, p 604 (2020)
The induction of a potent and long-lasting, broadly neutralizing antibody response is one of the most promising approaches in HIV-1 vaccination. Recently, we demonstrated that Gag-specific T helper cells induced by DNA priming can enhance and modulat
Externí odkaz:
https://doaj.org/article/9655ed6c06dc4fa289c9d0bb9f225e1c
Autor:
Pierre Tannig, Antonia Sophia Peter, Dennis Lapuente, Stephan Klessing, Anna Schmidt, Dominik Damm, Matthias Tenbusch, Klaus Überla, Vladimir Temchura
Publikováno v:
Vaccines, Vol 8, Iss 4, p 570 (2020)
Due to the low efficacy and the need for seasonal adaptation of currently licensed influenza A vaccines, the importance of alternative vaccination strategies is increasingly recognized. Considering that DNA vaccines can be rapidly manufactured and re
Externí odkaz:
https://doaj.org/article/80074c0243aa4d8b920c3d5c3b9515c0
Autor:
Pierre Tannig, Antonia Sophia Peter, Dennis Lapuente, Stephan Klessing, Dominik Damm, Matthias Tenbusch, Klaus Überla, Vladimir Temchura
Publikováno v:
Vaccines, Vol 8, Iss 1, p 27 (2020)
The importance of a balanced TH1/TH2 humoral immune response against the HIV-1 envelope protein (Env) for antibody-mediated HIV-1 control is increasingly recognized. However, there is no defined vaccination strategy to raise it. Since immune checkpoi
Externí odkaz:
https://doaj.org/article/b11748c22f39473c8006a055ee75f532
Autor:
Klessing, Stephan1 (AUTHOR), Peter, Antonia Sophia1 (AUTHOR), Fraedrich, Kirsten1 (AUTHOR), Wagner, Jannik T.1 (AUTHOR), Kummer, Mirko2,3 (AUTHOR), Deutschmann, Janina1 (AUTHOR), Steininger, Philipp1 (AUTHOR), Steibl, Hans-Dieter4 (AUTHOR), Überla, Klaus1 (AUTHOR) klaus.ueberla@fau.de
Publikováno v:
Viruses (1999-4915). Feb2023, Vol. 15 Issue 2, p397. 10p.
Autor:
Richel, Elie, Wagner, Jannik T., Klessing, Stephan, Di Vincenzo, Riccardo, Temchura, Vladimir, Überla, Klaus
Publikováno v:
Frontiers in Immunology; 2023, p1-16, 16p
Autor:
Hahn, Friedrich1, Schmalen, Adrian1, Setz, Christian1, Friedrich, Melanie1, Schlößer, Stefan1, Kölle, Julia1, Spranger, Robert1, Rauch, Pia1, Fraedrich, Kirsten1, Reif, Tatjana1, Karius-Fischer, Julia1, Balasubramanyam, Ashok2, Henklein, Petra3, Fossen, Torgils4, Schubert, Ulrich1 Ulrich.Schubert@viro.med.uni-erlangen.de
Publikováno v:
PLoS ONE. 4/7/2017, Vol. 12 Issue 4, p1-29. 29p.
Publikováno v:
NewsRx COVID-19 Weekly; 2/17/2023, p22-22, 1p
Autor:
Klessing, Stephan, Temchura, Vladimir, Tannig, Pierre, Peter, Antonia Sophia, Christensen, Dennis, Lang, Roland, Überla, Klaus
Publikováno v:
Vaccines; Dec2020, Vol. 8 Issue 4, p604, 1p